L Lim, S E Hulsebosch, C Gilor, K L Reagan, L Kopecny, A D Maggiore, K L Phillips, P H Kass, W Vernau, R W Nelson
The Journal of small animal practice 2023 JanThis study aims to re-evaluate the low-dose dexamethasone suppression test 8-hour cortisol cut-point for the diagnosis of hypercortisolism in dogs using a solid-phase, competitive chemiluminescent enzyme immunoassay. Twenty-seven client-owned dogs with naturally occurring hypercortisolism and 30 healthy control dogs were prospectively recruited. Performance of the low-dose dexamethasone suppression test was assessed using sensitivity, specificity and a receiver operating characteristic curve compared to a clinical diagnosis of hypercortisolism including response to treatment. Twenty-four dogs were diagnosed with pituitary-dependent hypercortisolism and three with adrenal-dependent hypercortisolism. In 30 healthy control dogs, 8-hour post-dexamethasone cortisol concentrations ranged from 5.5 to 39 nmol/L. A receiver operating characteristic curve curve constructed from the 8-hour post-dexamethasone cortisol concentrations of hypercortisolism and control dogs demonstrated that the most discriminatory cut-point was more than 39 nmol/L with sensitivity of 85.2% (95% confidence interval, 67.5% to 94.1%) and specificity of 100% (95% confidence interval, 88.7% to 100.0%) and an area under the curve of 0.963. The optimal cut-point of more than 36 nmol/L proposed by this study is similar to the currently accepted 8-hour cortisol concentration cut-point for diagnosing hypercortisolism when using a solid-phase, competitive chemiluminescent enzyme immunoassay. © 2022 British Small Animal Veterinary Association.
L Lim, S E Hulsebosch, C Gilor, K L Reagan, L Kopecny, A D Maggiore, K L Phillips, P H Kass, W Vernau, R W Nelson. Re-evaluation of the low-dose dexamethasone suppression test in dogs. The Journal of small animal practice. 2023 Jan;64(1):12-20
PMID: 36089334
View Full Text